Evaluation of smell and taste dysfunctions concurrent otolaryngological symptoms in SARS-CoV-2 positive patients

Evaluation of smell and taste dysfunctions concurrent otolaryngological symptoms in SARS-CoV-2 positive patients

Olfactory dysfunction can develop at any time interval of the disease, however mostly emerged earlier phases of the COVID-19. In this present study our aim was to evaluate the smell and taste dysfunctions concurrent otolaryngological symptoms in COVID-19 positive patients. We conducted this prospective study at xxxx Training and Research Hospital between December 2020 and January 2021. 197 patients were participated to the study. Patients who had been confirmed as COVID-19 positive by real- time polymerase chain reaction and with taste and /or smell dysfunction symptoms were included. We divided participants into four groups according to their ages. Ages between 18-30 was determined as Group1, 31-40 as Group 2, 41-50 as Group 3, ages 51 and more than as Group 4. A questionnaire was prepared including questions about age, gender, otorhinolaryngological symptoms, chronic illness, previous head injury, smoking, the olfactory and taste dysfunctions during COVID-19. A statistically significant difference was found between smell dysfunction scores and gender (z= 2.100; p = 0.036). The severity of smell dysfunction was higher in females. Hospitalized patients had higher smell dysfunction onset day than those who were not hospitalized. Both smell and taste dysfunctions were more often and the average duration of both disturbances were high in Group 2. The severity of the smell dysfunction was higher in females and appeared as a later symptom in hospitalized patients and continued longer in patients with nasal obstruction. Taste dysfunction continued longer in patients with nasal obstruction, nasal congestion, and sore throat.

___

  • 1. Sayin I, Yasar KK, Yazici ZM. Taste and smell impairment in COVID-19: An AAO-HNS anosmia reporting tool-based comparative study. Otolaryngol Head Neck Surg. 2020;163:473-79.
  • 2. Lee Y, Min P, Lee S, et al. Prevalence and duration of acute loss of smell or taste in COVID-19 Patients. J Korean Med Sci. 2020;11;35:e174.
  • 3. Meng X, Deng Y, Dai Z, et al. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41:102581.
  • 4. Chary E, Carsuzaa F, Trijolet JP, et al. Prevalence and recovery from olfactory and gustatory dysfunctions in Covid-19 infection: A prospective multicenter study. Am J Rhinol Allergy. 2020;34:686-93.
  • 5. Ozcelik Korkmaz M, Egilmez OK, Ozcelik MA, et al. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol. 2020;3:1-11.
  • 6. Dell'Era V, Farri F, Garzaro G, et al. Smell and taste disorders during COVID-19 outbreak: Cross-sectional study on 355 patients. Head Neck. 2020;42:1591-96.
  • 7. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251-61.
  • 8. Vaira LA, Salzano G, Deiana G, et al. Anosmia and ageusia: common findings in 384 COVID-19 patients. Laryngoscope. 2020;130:1787.
  • 9. Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–90.
  • 10. Moein S.T., Hashemian S.M.R., Mansourafshar B., et al. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10:944-50.
  • 11. Speth MM, Singer-Cornelius T, Oberle M,et al. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, Severity, timing, and associated characteristics. Otolaryngol Head Neck Surg. 2020;163:114-120.
  • 12. Kaye R, Chang CWD, Kazahaya K,et al. COVID-19 anosmia reporting tool: Initial findings. Otolaryngol Head Neck Surg. 2020;163:132-34.
  • 13. Yan CH, Faraji F, Prajapati DP, et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.Int Forum Allergy Rhinol. 2020;10:806-13.
  • 14. Wang Y, Kang H, Liu X,et al. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARSCoV- 2 outbreak. J Med Virol. 2020;92:538-39.
  • 15. Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323:2089-90.
  • 16. Eliezer M, Hautefort C, Hamel AL, et al. Sudden and complete olfactory loss of function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020 1;146:674-75.
  • 17. Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg. 2020;163:96-7.
  • 18. Sakalli E, Temirbekov D, Bayri E,et al. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients. Am J Otolaryngol. 2020;41:102622.
  • 19. Mullol J, Alobid I, Mariño-Sánchez F, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep. 2020;3;20:61.
  • 20. Song J, Deng YK, Wang H, et al. Self-reported taste and smell disorders in patients with COVID-19: Distinct features in China. Curr Med Sci. 2021;41:14-23.
  • 21. Klopfenstein T, Kadiane-Oussou NJ, Toko L, et al. Features of anosmia in COVID-19. Med Mal Infect. 2020;50:436-39.
  • 22. Gorzkowski V, Bevilacqua S, Charmillon A, et al. Evolution of olfactory disorders in COVID-19 patients. Laryngoscope. 2020;130:2667-73.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: 4
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

The efficacy of Pharmacomechanical catheter-directed thrombolysis in patients with concomitant deep vein thrombosis and pulmonary embolism: A retrospective analysis of 26 patients

Emced Khalil

Readability levels of patient information texts regarding cataract surgery on websites

Asena Keles Sahin, Enes Uyar

Hepatopancreaticobiliary injuries during the COVID-19 pandemic

Murat Derebey, Mahmut Arif Yuksek

Evaluation of serum perlecan levels in pregnancy with mild and severe preeclampsia

Tufan Arslanca, Muhammed Seyi̇thanoglu, Ugurkan Erkayiran, Abdullah Tok, Seli̇m Karakucuk

Do cytokines play role in the pathogenesis of mucopolysaccharidosis

Gursel Biberoglu, Asli Inci, Ilyas Okur, Leyla Tumer, Fatih Suheyl Ezgu, Canan Demirtas

Pharmacological and biological features of ethanol extract of Salvia virgata Jacq.

Merve Ergul, Nuraniye Eruygur, Tansu Uskutoglu, Esra Uçar, Mehmet Atas, Belgin COŞGE ŞENKAL, Halil BAL

Medial support is the critical risk factor for preventing failure after plating of proximal humerus fractures

Necmettin Turgut, Mehmet Ekinci

Evaluation of inflammatory markers in bipolar disorder: A comparative study

Ibrahim Eren, Memduha Aydin, Ali Metehan Caliskan, Ikbal Inanli

Distal radius torus fractures overlooked in emergency department: What happens?

Serdar Toy, Abdullah Osman Kocak, Ahmet Kose, Sultan Tuna AKGOL GUR, Mehmet Cenk Turgut

The role of combined use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis in pediatric intensıve care unit

Yasemin Ay ALTİNTOP, Ayse Betul ERGUL, Ayşe Nedret KOÇ, Mustafa Altay ATALAY